CellaVision's CEO Yvonne Mårtensson wins the 2009 Biotech Builder
Award
(Thomson Reuters ONE) - Yvonne Mårtensson, CEO of CellaVision, has been awarded the 2009Biotech Builder prize for developing CellaVision from concept to afully functioning commercial business, as well as for hercontributions to the biotechnology industry in the ÿresund region.The prize was awarded yesterday at the Biotech Builders yearlymeeting in Denmark.This is the seventh year that Biotech Builders brings attention to asuccessful individual in the industry through awarding this prize.This is the first year that the prize is given to a Swede. The jury'smotivation reads:Yvonne Mårtensson has developed CellaVision from concept to a fullyfunctioning commercial business with a turnover of SEK 100 millionand positive figures last year. She has taken the company throughmany challenges with small financial means by combining the soft andtough aspects of her leadership style. In addition to this she hasalso contributed to the development of broader networking betweencompanies in Medicon Valley, the pharmaceutical and biotechnologicalindustry, as well as the research community in the ÿresund region."It is a great honor for me to receive this prize considering theother well established companies from this region that were in thecompetition," says Yvonne Mårtensson. "My colleagues and I have givena lot of time and energy to CellaVision through the years, and theBiotech Builder Award honors this. It will make CellaVision morecompetitive and contribute to further growth."In 2008 CellaVision presented its best sales and results in thehistory of the company. For the first time sales increased to overSEK 100 million while the operating result increased to SEK 13million. Amongst other events during the year CellaVision establishedits own sales organization in the USA, the subsidiary CellaVisionJapan K.K. was launched, and the range of products was widened withan application for body fluids. During the first part of 2009CellaVision improved its gross margin and the next generation ofanalyzers was launched in Europe. As of now, more than 500 analyzershave been sold to approximately the same number of customers, whichare both hospital and commercial laboratories in mainly Europe andNorth America.Biotech Builders is a Danish and Swedish networking organization forpharmaceutical, biotechnology, and medical technology companies inthe ÿresund region. It is a non-profit organization and annuallyorganizes a meet for business leaders in the region. For moreinformation on Biotech Builders, visit www.biotechbuilders.com.For more information, please contact:Yvonne Mårtensson, CEO, CellaVision ABPhone: +46 46 286 44 00. E-mail: yvonne.martensson(at)cellavision.comAbout CellaVisionCellaVision AB develops, markets, and sells market leading imageanalysis based systems for routine analysis of blood and other bodyfluids. The company has a core competence in development of softwareand hardware for automatic image analysis of cells and cell changesfor applications in health and medical care. The company develops andmarkets systems for automatic differentials of white blood cells andred morphology, and software for education and quality assurance ofdifferentials. The company's associates have expertise in advancedimaging analysis, artificial intelligence, and automated microscopy.The company headquarters are in Lund, Sweden. The company also hassubsidiaries in Florida, USA, Toronto, Canada and Yokohama, Japan.For more information, visit www.cellavision.com.CellaVision's share is listed on First North Premier at the OMXStockholm Stock Exchange. The company's Certified Advisor is RemiumAB.This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 21.08.2009 - 15:04 Uhr
Sprache: Deutsch
News-ID 4958
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 333 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CellaVision's CEO Yvonne Mårtensson wins the 2009 Biotech Builder
Award"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
